.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Mallinckrodt
Fish and Richardson
Daiichi Sankyo
Cantor Fitzgerald
Teva
Covington
Novartis
Colorcon

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021625

« Back to Dashboard

NDA 021625 describes M.V.I. ADULT, which is a drug marketed by Hospira and is included in two NDAs. It is available from one supplier. Additional details are available on the M.V.I. ADULT profile page.

The generic ingredient in M.V.I. ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k profile page.

Summary for 021625

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E','VITAMIN K') AND hsdb_d' at line 1
Tradename:1
Applicant:1
Ingredient:1
Patents:0